Delivery Order SPE2DR25D2216-SPE2DR26F7VA1
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count package), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28-count) under a firm fixed price contract. This non-set-aside award, issued on July 17, 2025, with an ultimate completion date of August 7, 2025, represents a pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,983.68 for IMBRUVICA 280 MG tablets (28-count) under a firm fixed-price contract with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside delivery order represents a continuation of the company's pharmaceutical supply services to federal military and healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,983.68 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) on November 12, 2025, with completion targeted for December 4, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,967.36 to supply 28 tablets of Imbruvica 420 mg under a firm fixed-price contract. The award, issued on December 3, 2025, with an ultimate completion date of December 24, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,575.75 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order executed on August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,967.36 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count packaging) under a firm fixed-price contract. The award, made on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a non-competitive delivery order issued against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $7,983.68 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Imbruvica 280 mg tablets (28-count) with a completion date of December 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,575.75 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 140 mg tablets (28-count packaging) with a completion deadline of June 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $7,983.68 to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28-count packages) with a firm fixed price contract type. This delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office location in...
- SPE2DR25D2216Indefinite Delivery Contract
- SPE2DR25D2216-SPE2DR26F7VA1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,328.12 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) with a firm fixed-price structure and completion deadline of February 2, 2026. This non-set-aside award was competitively procured and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that runs through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with the parent company Cencora, Inc. (doing business as AmerisourceBergen) holding the overarching IDC that enables supply of a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's role in supporting the military healthcare supply chain through the DLA Medical Supply Chain, delivering specialty pharmaceuticals to military treatment facilities and veteran healthcare programs worldwide. The award reflects AmerisourceBergen's competitive capability to fulfill federal procurement requirements for essential pharmaceutical commodities, with the broader IDC vehicle positioning the contractor to efficiently deliver diverse medical products required by the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 1/8/26 |